Mutations in ASXL1 and/or TET2 Identify a Subset with Worse Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasms

被引：0

作者：

Xu, Mina ^{[1
]}

Thakkar, Devang ^{[2
]}

Panse, Gauri ^{[1
]}

Yan, Jiong ^{[3
,4
]}

Minden, Mark ^{[5
]}

Zandi, Sasan ^{[6
]}

Naresh, Kikkeri ^{[7
]}

Czader, Magdalena ^{[8
]}

Love, Cassandra ^{[2
]}

Happ, Lanie ^{[9
]}

Koff, Jean ^{[10
]}

Jaye, David ^{[11
]}

Michael, Churnetski ^{[10
]}

Arildsen, Mary Ann ^{[12
]}

Juskevicius, Ridas ^{[13
]}

Soliman, Dina ^{[14
]}

Louissaint, Abner ^{[15
]}

Mckinney, Matthew ^{[2
]}

Sojitra, Payal ^{[16
]}

Yin, C. Cameron ^{[17
]}

Ondrejka, Sarah ^{[18
]}

Tse, Eric ^{[19
]}

Dave, Sandeep ^{[2
]}

机构：

[1] Yale Univ, New Haven, CT USA

[2] Duke Univ, Durham, NC USA

[3] Univ Hlth Network, Lab Med Program, Dept Anat Pathol, Toronto, ON, Canada

[4] Univ Toronto, Toronto, ON, Canada

[5] Univ Hlth Network, Toronto, ON, Canada

[6] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada

[7] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[8] Indiana Univ, Indianapolis, IN USA

[9] Data Driven Biosci, Durham, NC USA

[10] Emory Univ, Atlanta, GA USA

[11] Emory Univ, Sch Med, Atlanta, GA USA

[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[13] Pathgroup, Nashville, TN USA

[14] Hamad Med Corp, Doha, Qatar

[15] Massachusetts Gen Hosp, Boston, MA 02114 USA

[16] Univ Med & Dent New Jersey, New Brunswick, NJ USA

[17] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[18] Cleveland Clin, Cleveland, OH USA

[19] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China

来源：

LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1210

引用

页码：S1258 / S1259

页数：2

共 50 条

[41] ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival
Argote, Juliana Alvarez
Dasanu, Constantin A.
CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 757 - 763
[42] Diversity of DNMT3A, TET2, and ASXL1 Gene Variants in Patients With Acute Myeloid Leukemia (AML)
Kashlakova, Anastasia
Biderman, Bella
Sidorova, Yulia
Lukianova, Irina
Bessmertnyy, Dmitry
Fidarova, Zalina
Obukhova, Tatyana
Julhakyan, Hunan
Sudarikov, Andrey
Parovichnikova, Elena
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S275 - S275
[43] DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study
Segura-Diaz, Adrian
Stuckey, Ruth
Florido, Yanira
Sobas, Marta
Alvarez-Larran, Alberto
Ferrer-Marin, Francisca
Perez-Encinas, Manuel
Carreno-Tarragona, Gonzalo
Fox, Maria L.
Vega, Barbara Tazon
Cuevas, Beatriz
Rodriguez, Juan F. Lopez
Farias-Sanchez, Nuria
Gonzalez-Martin, Jesus M.
Gomez-Casares, Maria T.
Bilbao-Sieyro, Cristina
THROMBOSIS AND HAEMOSTASIS, 2024, 124 (07) : 669 - 675
[44] Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
Traina, Fabiola
Visconte, Valeria
Jankowska, Anna M.
Makishima, Hideki
O'Keefe, Christine L.
Elson, Paul
Han, Yingchun
Hsieh, Fred H.
Sekeres, Mikkael A.
Mali, Raghuveer Singh
Kalaycio, Matt
Lichtin, Alan E.
Advani, Anjali S.
Duong, Hien K.
Copelan, Edward
Kapur, Reuben
Olalla Saad, Sara T.
Maciejewski, Jaroslaw P.
Tiu, Ramon V.
PLOS ONE, 2012, 7 (08):
[45] Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
Roche-Lestienne, C.
Marceau, A.
Labis, E.
Nibourel, O.
Coiteux, V.
Guilhot, J.
Legros, L.
Nicolini, F.
Rousselot, P.
Gardembas, M.
Helevaut, N.
Frimat, C.
Mahon, F-X
Guilhot, F.
Preudhomme, C.
LEUKEMIA, 2011, 25 (10) : 1661 - 1664
[46] Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
C Roche-Lestienne
A Marceau
E Labis
O Nibourel
V Coiteux
J Guilhot
L Legros
F Nicolini
P Rousselot
M Gardembas
N Helevaut
C Frimat
F-X Mahon
F Guilhot
C Preudhomme
Leukemia, 2011, 25 : 1661 - 1664
[47] Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms
Hussein, Kebede
Abdel-Wahab, Omar
Lasho, Terra L.
Van Dyke, Daniel L.
Levine, Ross L.
Hanson, Curtis A.
Pardanani, Animesh
Tefferi, Ayalew
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (01) : 81 - 83
[48] Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Laribi, Kamel
de Materre, Alix Baugier
Sobh, Mohamad
Cerroni, Lorenzo
Valentini, Caterina Giovanna
Aoki, Tomohiro
Suzuki, Ritsuro
Takeuchi, Kengo
Frankel, Arthur E.
Cota, Carlo
Ghez, David
Le Calloch, Ronan
Pagano, Livio
Petrella, Tony
BLOOD ADVANCES, 2020, 4 (19) : 4838 - 4848
[49] Myelodysplastic Syndromes with EZH2 Mutations Frequently Show Multilineage Dysplasia, Chromosome 7 Alterations and Concomitant Mutations in ASXL1, RUNX1 and TET2
Sakhdari, Ali
Routbort, Mark
Bueso-Ramos, Carlos
Patel, Keyur
Luthra, Rajyalakshmi
Ok, Chi Young
Loghavi, Sanam
Zuo, Zhuang
Yin, C. Cameron
Khoury, Joseph
Medeiros, L. Jeffrey
Kanagal-Shamanna, Rashmi
MODERN PATHOLOGY, 2018, 31 : 549 - 550
[50] ASXL1/ TET2 Genotype-Based Risk Stratification Outperforms ASXL1 Mutational Impact and Is Independent of Mutant Variant Allele Fractions (VAF) in CMML
Csizmar, Clifford M.
Gurney, Mark
Kanagal-Shamanna, Rashmi
Chien, Kelly S.
Hammond, Danielle E.
Lasho, Terra L.
Finke, Christy M.
Dean, Christopher
Mangaonkar, Abhishek A.
Gangat, Naseema
Tefferi, Ayalew
Alkhateeb, Hassan
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
Patnaik, Mrinal M.
BLOOD, 2023, 142

← 1 2 3 4 5 →